big dump at 1.4....why?, page-51

Well ANP has had a rough history, many have been burnt on this baby, LT and traders.

However this pharma stock is still at the developmental stage, but once the first drugs pass trials and start selling, its just going to snowball from there. Why? By the very nature of the technology. These guys are working with a Human DNA roadmap which has only become available in recent years. This roadmap is a massive help in developing vaccines for diseases with a genetic origin quickly and more cheaply than other methods, and for up to 30,000 genetic targets (currents medicines focus on only 600). The tech produces minimal (and known) side effects.

Its basically next-generation medicine, which long-term should be able to take market share from existing medications, as well as solving a whole gamut of diseases with no known cure, or even for diseases which are yet to be discovered.

Its that revolutionary, and I think many without the correct science background cant truly appreciate the potential, which is a big part of what leaves it grossly undervalued...for now.

My thoughts are in a few years time, once the market realises this company is knocking down whatever it touches, $2.50 per share will be achievable, which will set up anyone who got in at the ground floor (where we are again) an early retirement thank you very much. :)

Sorry if this comes across as an up-ramp. I'm honestly just trying to be objective about this stock (as objective as my subjective opinion can be ;) )